These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 19822585)

  • 1. Athletic participation in severe hemophilia: bleeding and joint outcomes in children on prophylaxis.
    Ross C; Goldenberg NA; Hund D; Manco-Johnson MJ
    Pediatrics; 2009 Nov; 124(5):1267-72. PubMed ID: 19822585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China.
    Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J
    Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia B.
    Monahan PE; Liesner R; Sullivan ST; Ramirez ME; Kelly P; Roth DA
    Haemophilia; 2010 May; 16(3):460-8. PubMed ID: 20059559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs.
    Tagliaferri A; Franchini M; Coppola A; Rivolta GF; Santoro C; Rossetti G; Feola G; Zanon E; Dragani A; Iannaccaro P; Radossi P; Mannucci PM
    Haemophilia; 2008 Sep; 14(5):945-51. PubMed ID: 18540895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sports participation in selected children with brachial plexus birth palsy.
    Bae DS; Zurakowski D; Avallone N; Yu R; Waters PM
    J Pediatr Orthop; 2009; 29(5):496-503. PubMed ID: 19568024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study.
    Shapiro AD; Donfield SM; Lynn HS; Cool VA; Stehbens JA; Hunsberger SL; Tonetta S; Gomperts ED;
    Pediatrics; 2001 Dec; 108(6):E105. PubMed ID: 11731632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation and risk-taking behaviour in sports in children with haemophilia.
    Köiter J; van Genderen FR; Brons PP; Nijhuis-van der Sanden MW
    Haemophilia; 2009 May; 15(3):686-94. PubMed ID: 19432922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy.
    Van den Berg HM; Dunn A; Fischer K; Blanchette VS
    Haemophilia; 2006 Jul; 12 Suppl 3():159-68. PubMed ID: 16684012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis in people with haemophilia.
    Coppola A; Franchini M; Tagliaferri A
    Thromb Haemost; 2009 Apr; 101(4):674-81. PubMed ID: 19350110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis for severe hemophilia: experience from Europe and the United States.
    van den Berg HM; Fischer K
    Semin Thromb Hemost; 2003 Feb; 29(1):49-54. PubMed ID: 12640565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score.
    Feldman BM; Funk SM; Bergstrom BM; Zourikian N; Hilliard P; van der Net J; Engelbert R; Petrini P; van den Berg HM; Manco-Johnson MJ; Rivard GE; Abad A; Blanchette VS
    Arthritis Care Res (Hoboken); 2011 Feb; 63(2):223-30. PubMed ID: 20862683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China.
    Tang L; Wu R; Sun J; Zhang X; Feng X; Zhang X; Luke KH; Poon MC
    Haemophilia; 2013 Jan; 19(1):27-34. PubMed ID: 23231016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed.
    van Dijk K; Fischer K; van der Bom JG; Grobbee DE; van den Berg HM
    Haemophilia; 2005 Sep; 11(5):438-43. PubMed ID: 16128885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central venous access devices in patients with hemophilia.
    Valentino LA; Kapoor M
    Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cost implications of target joints in Canadian boys with severe hemophilia A.
    Kern M; Blanchette V; Stain AM; Einarson TR; Feldman BM
    J Pediatr; 2004 Nov; 145(5):628-34. PubMed ID: 15520762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.